NONMEM Users Network Archive

Hosted by Cognigen

New job opportunity at Eli Lilly and Co.

From: Brian A Willis <willisba>
Date: Thu, 10 Jan 2019 13:14:41 +0000

Dear NMUsers community,

Lilly is looking for a talented individual who can help us expand our QSP m=
odeling capabilities.

The scientists in the department of PK/PD & Pharmacometrics at Lilly are th=
e leaders in research and development throughout the value chain from early=
 Discovery to clinical and post-drug approval with the goal of identifying =
and developing the right drug at the right dose for the right patient and l=
iving the model-informed paradigm of drug research and development. Our org=
anization is looking for a dynamic scientist who will be responsible for:

* Implementing Pharmacometrics and Quantitative System Pharmacology=
 modeling and simulation techniques to address key questions and influence =
portfolio decisions, including, but not limited to the application of drug-=
disease models, literature models, quantitative risk/benefit decision tools=
, quantitative systems pharmacology models and trial-design optimization an=

* Contributing to the development of novel QSP platform(s) for key =
disease states and improving existing QSP platforms.

* Anticipating and recognizing the issues affecting drug discovery/=
development and finding effective solutions by partnership and collaboratio=
n with cross-functional teams to enable decision-making.

* Providing scientific expertise in multi-disciplinary project team=
s to support the selection of the right target, molecule, dose, patient pop=
ulation and development strategies.

* Actively contribute to teams by engaging with fellow scientists w=
ithin the group and in other disciplines as well as interact, teach and col=
laborate with scientists in academia.

* Representing the group to increase visibility externally, through=
 key publications, active leadership in key scientific organizations, indus=
try trade groups or consortia.

In summary, in this exciting scientific and technical role, the qualified c=
andidate will have opportunities to apply MIDD principles to drug research =
and development strategies, help set direction for the organization, and dr=
ive successful implementation of the strategies to produce results.

The minimum qualifications for the job are

* a master's or advanced degree in a relevant scientific discipline=
 such as biological/pharmaceutical sciences, bioengineering or related fiel=
d with 8 years of relevant experience or

* a PhD and/or MD in a relevant scientific field such as biological=
/pharmaceutical sciences, bioengineering or related field.

The preferred candidate will have experience in quantitative pharmacology m=
odeling, an understanding of systems pharmacology principles, will be profi=
cient in quantitative modeling and simulation software (such as SimBiology,=
 NONMEM, MATLAB, R/S-plus etc.), will have excellent communication skills, =
and works effectively in team environments.

This position can be located either in Indianapolis, US, or Erl Wood, UK.

If you are interested in this exciting opportunity, please apply at:

Lilly is an EEO/Affirmative Action Employer and does not discriminate on th=
e basis of age, race, color, religion, gender, sexual orientation, gender i=
dentity, gender expression, national origin, protected veteran status, disa=
bility or any other legally protected status.

We look forward to hearing from you!

Best regards,

Brian A. Willis, PhD
Group Leader, Pharmacometrics
Research Advisor, PK/PD and Pharmacometrics

Eli Lilly and Company
Lilly Corporate Center, Indianapolis IN 46285 USA
317.651.1308 (office) | 317.220.9191 (mobile)

CONFIDENTIALITY NOTICE: This e-mail message (including all attachments) is =
for the sole use of the intended recipient(s) and may contain confidential =
and privileged information. Any unauthorized review, use, disclosure, copyi=
ng or distribution is strictly prohibited. If you are not the intended reci=
pient, please contact the sender by reply e-mail and destroy all copies of =
the original message.

Received on Thu Jan 10 2019 - 08:14:41 EST

The NONMEM Users Network is maintained by ICON plc. Requests to subscribe to the network should be sent to:

Once subscribed, you may contribute to the discussion by emailing: